ACW — Actinogen Medical Cashflow Statement
0.000.00%
Last trade - 00:00
- AU$66.91m
- AU$55.48m
- AU$0.37m
2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Changes in Working Capital | -9.19 | -1.68 | -0.415 | -6.53 | -4.14 |
Other Operating Cash Flow | |||||
Cash from Operating Activities | -10.5 | -2.86 | -1.72 | -9.52 | -8.7 |
Capital Expenditures | 0 | -0.023 | -0.006 | -0.003 | -0.037 |
Purchase of Fixed Assets | |||||
Other Investing Cash Flow Items | 0.072 | 0 | — | — | — |
Sale/Maturity of Investment | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | 0.072 | -0.023 | -0.006 | -0.003 | -0.037 |
Financing Cash Flow Items | 0.243 | 0.36 | -0.716 | -0.831 | 0 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 8.17 | 0.282 | 10.1 | 12.4 | 0.825 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | -2.26 | -2.6 | 8.38 | 2.91 | -7.91 |